ClinicalTrials.Veeva

Menu

A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes

Alcon logo

Alcon

Status and phase

Completed
Phase 3

Conditions

Acute Otitis Media

Treatments

Drug: Moxidex otic solution
Drug: Ofloxacin otic solution
Device: Tympanostomy tubes

Study type

Interventional

Funder types

Industry

Identifiers

NCT00578474
C-05-35

Details and patient eligibility

About

The purpose of this study is to determine if an otic formulation is safe and effective in treating middle ear infections in patients with ear tubes.

Enrollment

911 patients

Sex

All

Ages

6 months to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 6 months to 12 years old
  • Ear tubes in one or both ears
  • Ear drainage visible by the parent / guardian
  • Ear drainage less than 21 days
  • Ear tube may not be silver oxide, silver salt, t-type tube or long-shafted tube
  • Patient may not have non-tube otorrhea
  • Patient may not have had otic surgery other than tube placement in the last year
  • Patient may not be a menarchal female
  • Diabetic patients are not eligible
  • Patient may not have any disease or condition that would negatively affect the conduct of the study
  • Patient may not require any other systemic antimicrobial therapy during the study
  • Patient must meet certain medication washouts to be eligible
  • Analgesic use (other than acetaminophen) is not allowed
  • Patient may not be pre-disposed to neurosensory hearing loss
  • Other protocol-defined inclusion criteria may apply

Exclusion criteria

  • Age related
  • Other protocol-defined exclusion criteria may apply

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

911 participants in 2 patient groups

Moxidex
Experimental group
Description:
Moxidex otic solution
Treatment:
Drug: Moxidex otic solution
Device: Tympanostomy tubes
FLOXIN
Active Comparator group
Description:
Ofloxacin otic solution
Treatment:
Device: Tympanostomy tubes
Drug: Ofloxacin otic solution

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems